There are three main vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3), which are strategic intermediates in angiogenesis and in the construction of new networks of blood vessels required to hoard oxygen and nourishment for cancer growth.17 The gene discussed is KDR; the disease is cancer.